BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27419271)

  • 1. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
    Zeya B; Arjuman A; Chandra NC
    Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
    Arjuman A; Chandra NC
    Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S; Lubrano V
    Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB; Anwar K; Wirkowski P
    Curr Med Chem; 2009; 16(21):2641-52. PubMed ID: 19601801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).
    Ohki I; Amida H; Yamada R; Sugihara M; Ishigaki T; Tate S
    Biochim Biophys Acta; 2011 Feb; 1814(2):345-54. PubMed ID: 21035571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
    Chen M; Masaki T; Sawamura T
    Pharmacol Ther; 2002 Jul; 95(1):89-100. PubMed ID: 12163130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.
    Chen M; Narumiya S; Masaki T; Sawamura T
    Biochem J; 2001 Apr; 355(Pt 2):289-96. PubMed ID: 11284714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.
    Matsuda N; Ohkuma H; Naraoka M; Munakata A; Shimamura N; Asano K
    J Neurosurg; 2014 Sep; 121(3):621-30. PubMed ID: 24949677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
    Dunn S; Vohra RS; Murphy JE; Homer-Vanniasinkam S; Walker JH; Ponnambalam S
    Biochem J; 2008 Jan; 409(2):349-55. PubMed ID: 18092947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).
    Ishigaki T; Ohki I; Utsunomiya-Tate N; Tate SI
    J Biochem; 2007 Jun; 141(6):855-66. PubMed ID: 17416594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding.
    Francone OL; Tu M; Royer LJ; Zhu J; Stevens K; Oleynek JJ; Lin Z; Shelley L; Sand T; Luo Y; Kane CD
    J Lipid Res; 2009 Mar; 50(3):546-555. PubMed ID: 18845619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
    Ishiyama J; Taguchi R; Yamamoto A; Murakami K
    Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells.
    Pirillo A; Reduzzi A; Ferri N; Kuhn H; Corsini A; Catapano AL
    Atherosclerosis; 2011 Feb; 214(2):331-7. PubMed ID: 21130457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Cell Physiol Biochem; 2016; 38(5):1851-9. PubMed ID: 27160316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL
    Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S; Gautam AS
    Curr Atheroscler Rep; 2019 Jul; 21(10):38. PubMed ID: 31350594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
    Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
    Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein.
    Chen M; Inoue K; Narumiya S; Masaki T; Sawamura T
    FEBS Lett; 2001 Jun; 499(3):215-9. PubMed ID: 11423119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation.
    Roper BWR; Tiede C; Abdul-Zani I; Cuthbert GA; Jade D; Al-Aufi A; Critchley WR; Saikia Q; Homer-Vanniasinkam S; Sawamura T; McPherson MJ; Harrison MA; Tomlinson DC; Ponnambalam S
    J Biol Chem; 2023 Nov; 299(11):105325. PubMed ID: 37805141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.